Rapid Malaria, TB Dx Research Gets GHIT Boost
This article was originally published in Clinica
Executive Summary
The Japan-based Global Health Innovative Technology (GHIT) Fund has made a new multi-million dollar allocation to support neglected disease research, with a focus on potential breakthroughs in the diagnosis and treatment of malaria and tuberculosis.